Voigt Pulls Away from Top Sprinters Riding Into Avila Beach to Claim 2013 Amgen Tour of California Stage Victory
Published on May 16, 2013
Wind and Breakaway Led by 41-Year-Old Voigt Dictate Big Changes to Leader Board During Stage 5; van Garderen Will Wear Yellow Tomorrow
Cyclists Prepare to Race the Clock in San Jose Time Trial Friday During Stage 6; Event to Include 15 Top Women Riders
AVILA BEACH, Calif. (May 16, 2013) – With an imposing pack of top sprinters angling for the win 25 miles from the finish line in Avila Beach, RADIOSHACK LEOPARD TREK’S Jens Voigt (GER) made his second decisive attack of the day and struck out on his own to claim the Stage 5 of the 2013 Amgen Tour of California. Forty-one-year-old Voigt has ridden in seven of the eight editions of America’s Greatest Race, and has come close to the overall win, taking second place in 2007. Today’s win marked the 66th victory of his illustrious career.
“I felt like I’m a little bit stronger than the other guys in the break, but of course less fast than the sprinters, so the only chance for me to win is to come here [to the finish line] alone,” said Voigt, who at 41 is the oldest licensed racer in the world. “I went all in, and it worked. I’m a really happy man tonight. This is not the twilight of my career. Let’s call it ‘Indian Summer.’”
Besting the second- and third-place finishers by a whopping six seconds with his solo attack in the final 2.5 miles of the race, Voigt also orchestrated the defining move of the day – a breakaway of 17 elite riders about 82 miles into the 115-mile stage from Santa Barbara to Avila Beach, which the NBC Sports Network announcers called “the best move of the race in the last five days.”
Sensing a change in the punishing crosswinds as they rode through the town of Guadalupe, Voigt made a move to split the peloton, which forced overall leader Jose Acevedo (COL) of Team Jamis-Hagens Berman out of position, eventually causing him to lose the race’s overall lead. The group grew their advantage over the peloton to about a minute before reaching the tight turns in the final 200 meters to the finish. In addition to the stage win, these maneuvers also earned Voigt the Amgen Breakaway from Cancer® Most Courageous Rider Jersey today.
Acevedo (COL), who has been in the Amgen Race Leader Jersey since day two, got trapped along with four of the top-10 riders who had been in the overall standings before today. With the peloton ultimately unable to catch the escapees, BMC Racing Team’s
Tejay van Garderen (Boulder, CO), a favorite for the overall win, will wear the coveted yellow jersey for tomorrow’s individual time trials. This will give him the advantage of seeing the other riders’ times before he takes his turn on the 20-mile course in San Jose. With the race running south to north this year, van Garderen and his team will look to defend the leader jersey through the final day of racing, ending in Santa Rosa, Calif, where BMC Racing Team is based.
Some of the peloton’s top sprinters joined Voigt on the podium following the stage, with Team Garmin-Sharp’s Tyler Farrar (Seattle, Wash.) claiming second place today, and BMC Racing Team’s Thor Hushovd (NOR) in third. Cannondale Pro Cycling’s Peter Sagan (SVK), a favorite for today’s podium, ended the stage in fourth but holds onto the isit California Sprint Jersey.
BISSELL Pro Cycling’s Carter Jones (Boulder, Colo.) continues to hold onto the Nissan King of the Mountain Jersey, which he’s worn since the first day of racing. Bontrager Cycling Team’s 21-year-old Lawson Craddock (Austin, Texas) will continue in the Crunchies Best Young Rider Jersey, which he claimed in Stage 2.
Now in its eighth year, the 2013 Amgen Tour of California is running south to north for the first time, covering nearly 750 miles of California’s most scenic highways, roadways and coastlines over eight days, concluding in Santa Rosa, Calif., May 19. With one of the most difficult courses in race history, 113 elite cyclists (127 riders began the race, though several have been eliminated or abandoned due to time cuts, injury or illness) will compete through 12 Host Cities and 60,000 feet of climbing, a record for the race, including a first-time summit finish at Mt. Diablo in the Bay Area.
An important partner since the race’s inception, Amgen returns this year as the race title sponsor.
“Amgen’s innovative therapies help millions of people around the world in their fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses,” said Rolf Hoffmann, senior vice president of U.S. Commercial Operations at Amgen. “Through the Amgen Tour of California sponsorship, we are able to raise awareness of the contributions the biotechnology industry makes toward advances in medicine while also helping those impacted by cancer through Breakaway from Cancer.”
Amgen created the national Breakaway from Cancer initiative in 2005 as a complementary component to its sponsorship of the Amgen Tour of California. Breakaway from Cancer is a collaboration between Amgen and four nonprofit organizations – Prevent Cancer Foundation, Cancer Support Community, Patient Advocate Foundation and National Coalition for Cancer - Survivorship – who are all represented in the Breakaway from Cancer booth in the race Lifestyle Festival to provide information about access to resources. These organizations offer a broad range of support services complementing those provided by a patient’s team of healthcare professionals.
As part of the today’s race activities, Santa Barbara resident and cancer survivor Peggy Rantanen fired the official start gun and cancer survivor Thom Schulz had the honor of awarding Jens Voigt the Amgen Breakaway from Cancer Most Courageous Rider Jersey.
For access to resources or to learn more, visit breakawayfromcancer.com.
There are plenty of ways to take in the racing action through May 19, whether in person on the race course, via daily broadcasts on NBC Sports Network and NBC, or by downloading the free Tour Tracker app, which features live race updates, rider background and full race results. More information on all of the ways to watch is available atwww.amgentourofcalifornia.com.
STAGE 6 TOMORROW, PRESENTED BY CRUNCHIES FOOD COMPANY:
Thursday, May 16 – San Jose Individual Time Trial (19.6 mi/31.6 km)
Start Time – Women’s Time Trial: 12:45 p.m. PT
Start Time – Men’s Time Trial: 1 p.m. PT
Estimated Finish Time: 3:51 p.m. PT
Satellite Feed Time: 3:50 – 5 p.m. PT
(Coordinates can be found at http://www.amgentourofcalifornia.com/news/media-info.html)
Fifteen of the top professional women cyclists in the world with join the professional men for the individual time trial course in San Jose. The route will return to the race’s inaugural time trial course from 2006, with the addition of a wicked stinger at the end. The 20-mile course will feature a climb soon after the riders push off the starting ramp. As the racers navigate around beautiful lakes and golf courses, they will begin to prepare for the most difficult finish that any Amgen Tour of California time trial course has offered. When the cyclists make their final right hand turn on the route, they will come face-to-face with the climb up Metcalf Road to the finish. This 3-kilometer climb will see the riders gain nearly 1,000 feet in elevation with several pitches over a 10 percent grade.
About the Amgen Tour of California
The largest cycling event in America, the 2013 Amgen Tour of California is a Tour de France-style cycling road race, created and presented by AEG, that challenges the world’s top professional cycling teams to compete along a demanding course that stretches across nearly 750 miles of scenic California roadways, highways and coastlines from May 12-19, 2013. For more information about the race, please visit www.amgentourofcalifornia.com.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. To learn more about Amgen’s pioneering science and vital medicines, visitwww.amgen.com. Follow Amgen on www.twitter.com/amgen.
AEG is one of the leading sports and entertainment presenters in the world. AEG, a wholly owned subsidiary of The Anschutz Company, owns or controls a collection of companies including facilities such as STAPLES Center, The Home Depot Center, Sprint Center, The O2, Nokia Theatre L.A. LIVE and Best Buy Theater Times Square; sports franchises including the Los Angeles Kings (NHL), two Major League Soccer franchises, two hockey franchises operated in Europe, management of privately held shares of the Los Angeles Lakers, the Bay to Breakers foot race and the Amgen Tour of California cycling road race; AEG Live, the organization’s live-entertainment division, is a collection of companies dedicated to all aspects of live contemporary music performance, touring and a variety of programming and multi-media production. For more information, visit AEG today atwww.aegworldwide.com.
Media Contact: Eileen Tanner, GolinHarris, 509-521-2594, email@example.com